NCT07473648Recruiting
Multimodal Clinical Study of Electroconvulsive Therapy and Magnetic Seizure Therapy
Source: ClinicalTrials.gov · Last updated 17 Jul 2026
Brief summary (registry, in English)
To compare the efficacy and tolerability of Electroconvulsive Therapy (ECT) and Magnetic Seizure Therapy (MST) in patients with major depressive disorder (MDD).
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- First submitted
- 7 Feb 2026
- Start date
- 1 Sept 2025
- Primary completion date
- Dec 2027
- Lead sponsor
- The Second Hospital of Anhui Medical University
- Diseases
- Depression
- NCT number
- NCT07473648
What you commit to
- Study type: Interventional
- Planned participants: 200
- From 1 Sept 2025 to the primary completion date, Dec 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Prior neuromodulation within 3 months;
- Metal implants or claustrophobia.
Other illness
- Major systemic diseases;
Other
- Pregnancy or potential pregnancy;
Who the study is looking for
- Aged 12-80 years;
- Diagnosis confirmed by two psychiatrists per DSM-5;
- Stable medication regimen pre-enrollment;
- Indicated for neuromodulation OR with visual field defects.
Age in the registry: 12 years to 80 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Anhui Medical University Coordinator of this site? Confirm its status | Hefei | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.